NeurologyLive® Friday 5 — July 28, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Roundtable: Building a Greater Understanding for Dravet Syndrome

A duo of experts provide insight on various topics related to the advances in treatment options, diagnosis of the disorder, role of genetics, and potential future research and gene therapies.

2: Peer Exchange: Concluding Thoughts on Biosimilars in Multiple Sclerosis

In episode 11 of the "How Similar are Biosimilars? A look into the Future with Biosimilars in Multiple Sclerosis" Peer Exchange series, Amy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.

3: NeuroVoices: Alessio Travaglia, PhD, on Utilizing Available Alzheimer Biomarkers Properly

In the latest edition of our in-depth Q&A series, the director at the Foundation for the National Institutes of Health provided perspective on the effective ways to utilize currently available biomarkers for Alzheimer disease research.

4: Neurology News Network: The Safety of Other S1P Receptor Modulators in Multiple Sclerosis

Krzysztof Selmaj, MD, PhD, presents the key results on the safety of other sphinogine-1-phospate (S1P) receptor modulators, such as fingolimod and ponesimod, in the treatment of multiple sclerosis (MS).

5: Advancing Research With Remote Blood Collection for Alzheimer Biomarkers: Hanna Huber, PhD

The researcher in the department of neurochemistry at the University of Gothenburg in Sweden discussed bloodspot cards as a promising method for collecting blood samples in Alzheimer disease research. [WATCH TIME: 4 minutes]